Chinese gene therapy drug startup OBiO recently announced that it has completed a series C financing of over RMB300 million yuan.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
